Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Bristol-Myers Squibb divulges nonstructural protein 5B inhibitors

Sep. 7, 2016

Agents for RSV infections described in Aviragen Therapeutics patent

Sep. 6, 2016

Latvian Institute of Organic Synthesis patents LeuRS inhibitors

Sep. 6, 2016

Exeporfinium chloride demonstrates safety, tolerability and efficacy in U.S. clinical trial

Sep. 6, 2016

Dynavax provides update on recent dialogue with FDA regarding Heplisav-B BLA

Sep. 5, 2016

GSK initiates phase IIa trial of shigella vaccine in Kenya

Sep. 5, 2016

University of Dundee, GlaxoSmithKline develop novel compound for leishmaniasis

Sep. 2, 2016

SK Chemicals launches SKYCellflu Quadrivalent influenza vaccine in South Korea

Sep. 1, 2016

Arbutus Biopharma terminates exclusive license agreement with Kuros Biosciences

Aug. 31, 2016

GlaxoSmithKline tests novel antimalarial quinazolindiones

Aug. 31, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...